PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT01930903

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; primary purpose treatment
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Biotronik France (from the registry)
Registry
  • NCT NCT01930903
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01930903. Non-randomized; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon
Acronym
PaneLux PTCA
Condition
High Bleeding Risk Patients
Intervention (Device)
Pantera Lux Drug Eluting Balloon
Lead sponsor
Biotronik France (class: industry)
Collaborator
MedPass International (class: industry)

Record details

Record id
cardio:ct-nct01930903
Content hash
9674d0605af6eb7d7418ed253a6b3088407bc129089b9fb8c911128152f524c5